EmeritusDX, a cancer diagnostics company, has announced its expansion plans. The plan includes the occupation of a laboratory which immediately increases the laboratory footprint by 400%.
The move will support the growing demand for anatomic pathology and FISH testing and will accelerate the company's launch of molecular services.
The new laboratory, located in Irvine, CA, includes a custom cleanroom and automated liquid handlers to enable the launch of Molecular assays beginning in the third quarter of this year. Additionally, the Anatomic Pathology and FISH laboratory space has substantially expanded to accommodate the new equipment and employees needed to meet the projected test volumes.
"We feel fortunate to have found such an exceptional location to call home. Our new laboratory will help us continue to grow and innovate in order to keep pace with our clients' needs," said CEO, Robert Embree
Jason Allchin, the company's President, added: "This move further cements our commitment to expand our services and be the most trusted partner within cancer diagnostics."
